𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effects of neonatal treatment with 5,7-dihydroxytryptamine or 6-hydroxydopamine on the ontogenetic development of the audiogenic immobility reaction in the rat

✍ Scribed by Ernest Hård; Sven Ahlenius; Jörgen Engel


Publisher
Springer
Year
1983
Tongue
English
Weight
722 KB
Volume
80
Category
Article
ISSN
0033-3158

No coin nor oath required. For personal study only.

✦ Synopsis


The ontogenetic development of the audiogenic immobility reaction (freezing) was studied in rats given intracisternal injections of the neurotoxins 5,7-dihydroxytryptamine (5,7-DHT), 25 gg, or 6-hydroxydopamine (6-OHDA), 100 gg, neonatally (Day 1). The duration of the freezing response was strongly reduced in the 5,7-DHTtreated rats between 20" 30 days of age, when normal animals show very prolonged responses. During the same period increased motor activity was observed in the 6-OHDA-treated rats while only a slight reduction of the freezing response was noted. Biochemical analyses performed on brains from animals 35 days of age showed a selective reduction (about 50 %) of whole brain levels of serotonin in the 5,7-DHT-treated rats, while the noradrenaline levels were selectively reduced by about 60 % in the 6-OHDA rats. A longitudinal investigation on the effects of neonatal treatment with 5,7-DHT showed a persistent selective reduction of the whole brain level of serotonin up to at least 90 days of age. Since 5,7-DHT mainly affects the serotonergic pathways, the results suggest that the disturbances noted in the ontogeny of the freezing response may be due to interference with the developing serotonergic system.


📜 SIMILAR VOLUMES


Regulation of striatal neuropeptide mRNA
✍ C. Durand; A.M. Mathieu-Kia; M.-J. Besson; J. Penit-Soria 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 617 KB

The intrastriatal injection of 6-hydroxydopamine (6-OHDA) in newborn rats produces a marked striatal dopamine (DA) depletion, accompanied by a serotonin (5-HT) hyperinnervation and an up-regulation of 5-HT receptors. The aim of the present study was to investigate whether the increase in 5-HT 2 rece

Chronic treatment with the mGlu5R antago
✍ Maria Rosaria Domenici; Rosa Luisa Potenza; Alberto Martire; Roberto Coccurello; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 219 KB

## Abstract This study was designed to test whether chronic treatment with the metabotropic glutamate receptor 5 (mGlu5R) antagonist MPEP showed antiparkinsonian effects in rats unilaterally lesioned with 6‐hydroxydopamine (6‐OHDA) (a “classic” model of Parkinson's disease, PD), and to evaluate whe